Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
T De Witte, D Bowen, M Robin… - Blood, The Journal …, 2017 - ashpublications.org
An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellström-Lindberg… - Blood, The Journal …, 2013 - ashpublications.org
Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet,
an Expert Panel was selected according to the framework elements of the National Institutes …
an Expert Panel was selected according to the framework elements of the National Institutes …
Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes
BL Scott, MC Pasquini, BR Logan, J Wu… - Journal of Clinical …, 2017 - ascopubs.org
Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation
(HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with …
(HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with …
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …
Transplantation regularly publishes on the current practice and indications for …
[HTML][HTML] Defining the intensity of conditioning regimens: working definitions
A Bacigalupo, K Ballen, D Rizzo, S Giralt… - Biology of blood and …, 2009 - Elsevier
Defining conditioning regimen intensity has become a critical issue for the hemopoietic stem
cell transplant (HSCT) community. In the present report we propose to define conditioning …
cell transplant (HSCT) community. In the present report we propose to define conditioning …
Graft-versus-host disease
Haemopoietic-cell transplantation (HCT) is an intensive therapy used to treat high-risk
haematological malignant disorders and other life-threatening haematological and genetic …
haematological malignant disorders and other life-threatening haematological and genetic …
Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized …
Purpose To compare a reduced-intensity conditioning regimen (RIC) with a myeloablative
conditioning regimen (MAC) before allogeneic transplantation in patients with …
conditioning regimen (MAC) before allogeneic transplantation in patients with …
Myelodysplastic syndromes
A Tefferi, JW Vardiman - New England Journal of Medicine, 2009 - Mass Medical Soc
This review gives an account of the clinical and hematologic features of the myelodysplastic
syndromes. It supplies the latest classification of these disorders, discusses the cytogenetic …
syndromes. It supplies the latest classification of these disorders, discusses the cytogenetic …
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
JJ Cornelissen, A Gratwohl, RF Schlenk… - Nature reviews Clinical …, 2012 - nature.com
Allogeneic haematopoietic stem-cell transplantation (HSCT) is frequently applied as part of
the treatment in patients with acute myeloid leukaemia (AML) in their first or subsequent …
the treatment in patients with acute myeloid leukaemia (AML) in their first or subsequent …
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with …
BL McClune, DJ Weisdorf, TL Pedersen… - Journal of Clinical …, 2010 - ascopubs.org
Purpose Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)
primarily afflict older individuals. Hematopoietic cell transplantation (HCT) is generally not …
primarily afflict older individuals. Hematopoietic cell transplantation (HCT) is generally not …